Global Blood Screening Market Size study & Forecast, by Product Type (Instruments, Reagents & Kits) by Technology (Molecular Tests, Serology Tests), by End User (Independent Clinical Laboratories, Hospital-based Laboratories, Others) and Regional Analysis

Global Blood Screening Market Size study & Forecast, by Product Type (Instruments, Reagents & Kits) by Technology (Molecular Tests, Serology Tests), by End User (Independent Clinical Laboratories, Hospital-based Laboratories, Others) and Regional Analysis, 2023-2030

Global Blood Screening Market is valued approximately at USD XX Million in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Blood screening, also known as blood tests or blood work, is a medical procedure that involves analyzing a sample of a person's blood to assess various aspects of their health. It is a valuable tool in healthcare for diagnosing, monitoring, and managing a wide range of medical conditions. The key factors driving the market growth increasing blood donation, rising prevalence of blood-borne diseases, growing healthcare infrastructure, and increasing aging population are anticipated to support market growth.

Moreover, growing blood donation is anticipated to support the growth of the Blood Screening Market. The growing blood donations is increasing the demand for blood samples to screen for various diseases and infections. Thus, the growing blood donation is drive the demand for blood screening tests. According to Statista, in 2018, the number of blood donors in Japan was 4.71 million, and the number increased significantly and reached 5.09 million in 2021. As a result, the growing blood donation is anticipated to create the lucrative demand for the market during forecast period 2023-2030. Additionally, the cohesive government initiatives are anticipated to create lucrative opportunity for the market growth during forecast period 2023-2030. However, the development of alternative technologies stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Blood Screening Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the enhanced screening accuracy, prevalence of key market players, and rising prevalence of blood-borne diseases. Whereas, Asia Pacific is expected to grow with the fastest growth rate during the forecast period, owing to factors such as the growing healthcare infrastructure, public health initiatives, growing prevalence of blood-borne diseases, and increasing blood donation.

Major market player included in this report are:
Bio-Rad Laboratories, Inc.
Grifols, S.A.
F. Hoffmann-La Roche
Ortho Clinical Diagnostics
Becton, Dickinson and Company (BD)
DiaSorin S.p.A.
Thermo Fisher Scientific Inc.
Abbott
QUOTIENT Limited
Beckman Coulter, Ince
Recent Developments in the Market:
 March 2023, H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G NfL CSF and Lumipulse G NfL Blood assays for the fully automated random-access LUMIPULSE G immunoassay systems. These CLEIA (chemiluminescent enzyme immunoassay) assays allow for the quantitative measurement of Neurofilament light (NfL) in human Cerebrospinal fluid (CSF) and plasma/serum, respectively, within just 35 minutes.
Global Blood Screening Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered – Product Type, Technology, End User, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Instruments
Reagents & Kits

By Technology:
Molecular Tests
Serology Tests

By End User:
Independent Clinical Laboratories
Hospital-based Laboratories
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned
Bio-Rad Laboratories, Inc.
Grifols, S.A.
F. Hoffmann-La Roche
Ortho Clinical Diagnostics
Becton, Dickinson and Company (BD)
DiaSorin S.p.A.
Thermo Fisher Scientific Inc.
Abbott
QUOTIENT Limited
Beckman Coulter, Ince

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.